Central nervous system effects of current and emerging multiple sclerosis-directed immuno-therapies

Jack P Antel; Veronique E Miron

doi:10.1016/j.clineuro.2008.03.021

Central nervous system effects of current and emerging multiple sclerosis-directed immuno-therapies

Research output: Contribution to journal › Article › peer-review

Abstract

To review the direct and indirect effects on the central nervous system (CNS) of systemically administered immuno-modulatory therapies in use or under evaluation for the relapsing forms of multiple sclerosis (MS).

Original language	English
Pages (from-to)	951-7
Number of pages	7
Journal	Clinical Neurology and Neurosurgery
Volume	110
Issue number	9
DOIs	https://doi.org/10.1016/j.clineuro.2008.03.021
Publication status	Published - Nov 2008

Keywords

Animals
Multiple Sclerosis
Recombinant Proteins
Antineoplastic Agents
Humans
Interferon Type I
Peptides
Propylene Glycols
Sphingosine
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Central Nervous System
Immunosuppressive Agents

Access to Document

10.1016/j.clineuro.2008.03.021

Cite this

@article{3f9b149534e047a3aa9fad8b78846a7b,

title = "Central nervous system effects of current and emerging multiple sclerosis-directed immuno-therapies",

abstract = "To review the direct and indirect effects on the central nervous system (CNS) of systemically administered immuno-modulatory therapies in use or under evaluation for the relapsing forms of multiple sclerosis (MS).",

keywords = "Animals, Multiple Sclerosis, Recombinant Proteins, Antineoplastic Agents, Humans, Interferon Type I, Peptides, Propylene Glycols, Sphingosine, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Central Nervous System, Immunosuppressive Agents",

author = "Antel, {Jack P} and Miron, {Veronique E}",

year = "2008",

month = nov,

doi = "10.1016/j.clineuro.2008.03.021",

language = "English",

volume = "110",

pages = "951--7",

journal = "Clinical Neurology and Neurosurgery",

issn = "0303-8467",

publisher = "Elsevier",

number = "9",

}

TY - JOUR

T1 - Central nervous system effects of current and emerging multiple sclerosis-directed immuno-therapies

AU - Antel, Jack P

AU - Miron, Veronique E

PY - 2008/11

Y1 - 2008/11

N2 - To review the direct and indirect effects on the central nervous system (CNS) of systemically administered immuno-modulatory therapies in use or under evaluation for the relapsing forms of multiple sclerosis (MS).

AB - To review the direct and indirect effects on the central nervous system (CNS) of systemically administered immuno-modulatory therapies in use or under evaluation for the relapsing forms of multiple sclerosis (MS).

KW - Animals

KW - Multiple Sclerosis

KW - Recombinant Proteins

KW - Antineoplastic Agents

KW - Humans

KW - Interferon Type I

KW - Peptides

KW - Propylene Glycols

KW - Sphingosine

KW - Hydroxymethylglutaryl-CoA Reductase Inhibitors

KW - Central Nervous System

KW - Immunosuppressive Agents

U2 - 10.1016/j.clineuro.2008.03.021

DO - 10.1016/j.clineuro.2008.03.021

M3 - Article

C2 - 18502570

VL - 110

SP - 951

EP - 957

JO - Clinical Neurology and Neurosurgery

JF - Clinical Neurology and Neurosurgery

SN - 0303-8467

IS - 9

ER -

Central nervous system effects of current and emerging multiple sclerosis-directed immuno-therapies

Abstract

Keywords

Access to Document

Fingerprint

Cite this